Literature DB >> 22838107

Trimester-specific reference intervals for IFCC standardised haemoglobin A(1c): new criterion to diagnose gestational diabetes mellitus (GDM)?

P O'Shea1, C O'Connor, L Owens, L Carmody, G Avalos, L Nestor, K Lydon, F P Dunne.   

Abstract

We established trimester-specific reference intervals for IFCC standardised HbA(1c) in 311 non-diabetic Caucasian pregnant women (n = 246) and non-pregnant women (n = 65). A selective screening strategy based on risk factors for gestational diabetes was employed. Pregnancy trimester was defined as trimester 1 (T1, n = 40) up to 12 weeks + 6 days, trimester 2 (T2, n = 106) 13 to 27 weeks + 6 days, trimester 3 (T3, n = 100) > 28 weeks to delivery. The normal HbA(1c) reference interval for Caucasian non-pregnant women was 29-37 mmol/mol (DCCT: 4.8-5.5%), T1: 24-36 mmol/mol (DCCT: 4.3-5.4%), T2: 25-35 mmol/mol (DCCT: 4.4-5.4%), and T3: 28-39 mmol/mol (DCCT: 4.7-5.7%). HbA(1c) was significantly decreased in trimesters 1 (P < 0.01) and 2 (P < 0.001) compared to non-pregnant women. Retrospective application of selective screening to Caucasian women of the Atlantic DIP cohort determined that 5,208 met the criteria. 945 of those women (18.1%) were diagnosed with Gestational Diabetes Mellitus (GDM) using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) glucose concentration thresholds. HbA(1c) measurement within 2 weeks of the diagnostic Oral Glucose Tolerance Test (OGTT) was available in 622 of 945 (66%). Applying the decision threshold for T2: HbA(1c) > 35 mmol/mol (DCCT > 5.4%) identified 287 of 622 (46%) of those with GDM. HbA(1c) measurement in T2 (13 to 27 weeks) should be included in the diagnostic armamentarium for GDM. This would reduce the need for diagnostic OGTT in a significant number of women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22838107

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  6 in total

Review 1.  Is There a Role for HbA1c in Pregnancy?

Authors:  Ruth C E Hughes; Janet Rowan; Chris M Florkowski
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

Review 2.  Application of glycated hemoglobin in the perinatal period.

Authors:  Haiyan Yu; Xiaorong Qi; Xiaodong Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium.

Authors:  Katrien Benhalima; Paul Van Crombrugge; Roland Devlieger; Johan Verhaeghe; Ann Verhaegen; Luc De Catte; Chantal Mathieu
Journal:  Diabetol Metab Syndr       Date:  2013-11-11       Impact factor: 3.320

4.  Elevated glycated hemoglobin predicts macrosomia among Asian Indian pregnant women (WINGS-9).

Authors:  Balaji Bhavadharini; Manni Mohanraj Mahalakshmi; Mohan Deepa; Ranjani Harish; Belma Malanda; Arivudainambi Kayal; Anne Belton; Ponnusamy Saravanan; Unnikrishnan Ranjit; Ram Uma; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

5.  Predictive Value of First-Trimester Glycosylated Hemoglobin Levels in Gestational Diabetes Mellitus: A Chinese Population Cohort Study.

Authors:  Jianbin Sun; Sanbao Chai; Xin Zhao; Ning Yuan; Jing Du; Yufang Liu; Zhi Li; Xiaomei Zhang
Journal:  J Diabetes Res       Date:  2021-04-09       Impact factor: 4.011

6.  HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome.

Authors:  Ingrid Hov Odsæter; Arne Åsberg; Eszter Vanky; Sven Magnus Carlsen
Journal:  BMC Endocr Disord       Date:  2015-08-06       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.